Clinical Trials Browser

OTHER_GOV × Melanoma × apatinib × Clear all

NCT03383237 2017-12-27

Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma

Phase 2 Unknown

Melanoma